These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38416775)

  • 1. Effects of structurally distinct human HDAC6 and HDAC6/HDAC8 inhibitors against S. mansoni larval and adult worm stages.
    Gimmelli R; Papoff G; Saccoccia F; Lalli C; Gemma S; Campiani G; Ruberti G
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011992. PubMed ID: 38416775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production.
    Guidi A; Saccoccia F; Gennari N; Gimmelli R; Nizi E; Lalli C; Paonessa G; Papoff G; Bresciani A; Ruberti G
    Parasit Vectors; 2018 Dec; 11(1):668. PubMed ID: 30587243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and Phenotypical Characterization of
    Saccoccia F; Brindisi M; Gimmelli R; Relitti N; Guidi A; Saraswati AP; Cavella C; Brogi S; Chemi G; Butini S; Papoff G; Senger J; Herp D; Jung M; Campiani G; Gemma S; Ruberti G
    ACS Infect Dis; 2020 Jan; 6(1):100-113. PubMed ID: 31661956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Screening of Histone Deacetylase (HDAC) Inhibitors against Schistosoma mansoni.
    Hassan MM; Sedighi A; Olaoye OO; Häberli C; Merz A; Ramos-Morales E; de Araujo ED; Romier C; Jung M; Keiser J; Gunning PT
    ChemMedChem; 2022 Sep; 17(18):e202100622. PubMed ID: 35983937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
    de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
    Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages.
    Noce B; Di Bello E; Zwergel C; Fioravanti R; Valente S; Rotili D; Masotti A; Salik Zeya Ansari M; Trisciuoglio D; Chakrabarti A; Romier C; Robaa D; Sippl W; Jung M; Häberli C; Keiser J; Mai A
    ChemMedChem; 2023 Feb; 18(3):e202200510. PubMed ID: 36250286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosoma mansoni: In vivo evaluation of Phyllanthus amarus hexanic and ethanolic extracts.
    de Oliveira CNF; Frezza TF; Garcia VL; Figueira GM; Mendes TMF; Allegretti SM
    Exp Parasitol; 2017 Dec; 183():56-63. PubMed ID: 29074138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
    Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis.
    Alwan SN; Taylor AB; Rhodes J; Tidwell M; McHardy SF; LoVerde PT
    PLoS Pathog; 2023 Jul; 19(7):e1011018. PubMed ID: 37428793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.
    Barakat R; El Morshedy H
    Parasitology; 2011 Apr; 138(4):440-6. PubMed ID: 21078223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
    Sobhy MMK; Mahmoud SS; El-Sayed SH; Rizk EMA; Raafat A; Negm MSI
    Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme.
    Gower CM; Gehre F; Marques SR; Lamberton PHL; Lwambo NJ; Webster JP
    Parasit Vectors; 2017 Dec; 10(1):593. PubMed ID: 29197426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiparasitic properties of 4-nerolidylcatechol from Pothomorphe umbellata (L.) Miq. (Piperaceae) in vitro and in mice models with either prepatent or patent Schistosoma mansoni infections.
    Costa DS; Leal CM; Cajas RA; Gazolla MC; Silva LM; Carvalho LSA; Lemes BL; Moura RO; Almeida J; de Moraes J; da Silva Filho AA
    J Ethnopharmacol; 2023 Sep; 313():116607. PubMed ID: 37149066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors.
    Saccoccia F; Pozzetti L; Gimmelli R; Butini S; Guidi A; Papoff G; Giannaccari M; Brogi S; Scognamiglio V; Gemma S; Ruberti G; Campiani G
    J Biol Chem; 2022 Oct; 298(10):102375. PubMed ID: 35970392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni.
    Lotfy WM; Hishmat MG; El Nashar AS; Abu El Einin HM
    Pharm Biol; 2015 Aug; 53(8):1214-9. PubMed ID: 25609146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure.
    Sabra AN; Botros SS
    J Parasitol; 2008 Apr; 94(2):537-41. PubMed ID: 18564758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni.
    Padalino G; Ferla S; Brancale A; Chalmers IW; Hoffmann KF
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):559-570. PubMed ID: 30455056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the antioxidant defence in different developmental stages of Schistosoma mansoni by praziquantel and artemether.
    El-Bassiouni EA; Helmy MH; Saad EI; El-Nabi Kamel MA; Abdel-Meguid E; Hussein HS
    Br J Biomed Sci; 2007; 64(4):168-74. PubMed ID: 18236739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
    Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
    J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic analysis of reduced sensitivity to praziquantel in Schistosoma mansoni.
    Sanchez MC; Cupit PM; Bu L; Cunningham C
    Mol Biochem Parasitol; 2019 Mar; 228():6-15. PubMed ID: 30658180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.